Search Page

1

Cite

Share

Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma.

Jacinto AA, Batalha Filho ES, Viana LS, De Marchi P, Capuzzo RC, Gama RR, Boldrini Junior D, Santos CR, Pinto GDJ, Dias JM, Canton HP, Carvalho R, Radicchi LA, Bentzen S, Zubizarreta E, Carvalho AL. Jacinto AA, et al. Among authors: canton hp. BMC Cancer. 2018 Oct 23;18(1):1026. doi: 10.1186/s12885-018-4893-5. BMC Cancer. 2018. PMID: 30352576 Free PMC article. Clinical Trial.

Cite

Share

2

Cite

Share

Predicting the necessity of adding catheters to intracavitary brachytherapy for women undergoing definitive chemoradiation for locally advanced cervical cancer.

Palhares DMF, Marconi DG, Azevedo TL, Hess CB, Fregnani JHTG, Affonso RJ Jr, Veneziani ACLC, Canton HP, Gadia R, Spadim MD, Rossini RR, Kamrava M. Palhares DMF, et al. Among authors: canton hp. Brachytherapy. 2018 Nov-Dec;17(6):935-943. doi: 10.1016/j.brachy.2018.07.003. Epub 2018 Aug 9. Brachytherapy. 2018. PMID: 30100273

Cite

Share

3

Cite

Share

RAdiotherapy for Prostate cancer using HYpofractionation Directed by UltraSound (RAPHYDUS): a Brazilian public health care system study.

Faustino FLC, Altei WF, Canton HP, Morato L, de Paula LLRJ, Salvador GB, Fonseca DSL, Gonçalves TK, Kupelian PA, Zaparolli JC, Ercolin L, Marconi DG. Faustino FLC, et al. Among authors: canton hp. Pract Radiat Oncol. 2022 Apr 21:S1879-8500(22)00126-6. doi: 10.1016/j.prro.2022.04.001. Online ahead of print. Pract Radiat Oncol. 2022. PMID: 35462055

Cite

Share

4

Cite

Share

Regulation of serotonin-2C receptor G-protein coupling by RNA editing.

Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E, Emeson RB. Burns CM, et al. Among authors: canton h. Nature. 1997 May 15;387(6630):303-8. doi: 10.1038/387303a0. Nature. 1997. PMID: 9153397

Cite

Share

5

Cite

Share

Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors.

Smith RL, Canton H, Barrett RJ, Sanders-Bush E. Smith RL, et al. Among authors: canton h. Pharmacol Biochem Behav. 1998 Nov;61(3):323-30. doi: 10.1016/s0091-3057(98)00110-5. Pharmacol Biochem Behav. 1998. PMID: 9768567

Cite

Share

6

Cite

Share

Identification of rat serotonin 5-HT2C receptors as glycoproteins containing N-linked oligosaccharides.

Backstrom JR, Westphal RS, Canton H, Sanders-Bush E. Backstrom JR, et al. Among authors: canton h. Brain Res Mol Brain Res. 1995 Nov;33(2):311-8. doi: 10.1016/0169-328x(95)00156-m. Brain Res Mol Brain Res. 1995. PMID: 8750891

Cite

Share

7

Cite

Share

S 14671: a novel naphthylpiperazine 5-HT1A agonist of high efficacy and exceptional in vivo potency.

Millan MJ, Canton H, Rivet JM, Lejeune F, Laubie M, Lavielle G. Millan MJ, et al. Among authors: canton h. Eur J Pharmacol. 1991 Oct 15;203(2):319-22. doi: 10.1016/0014-2999(91)90734-8. Eur J Pharmacol. 1991. PMID: 1839284

Cite

Share

8

Cite

Share

Glutamate and glycine co-activate while polyamines merely modulate the NMDA receptor complex.

Lehmann J, Colpaert F, Canton H. Lehmann J, et al. Among authors: canton h. Prog Neuropsychopharmacol Biol Psychiatry. 1991;15(2):183-90. doi: 10.1016/0278-5846(91)90079-g. Prog Neuropsychopharmacol Biol Psychiatry. 1991. PMID: 1678540

Cite

Share

9

Cite

Share

Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines.

Peglion JL, Canton H, Bervoets K, Audinot V, Brocco M, Gobert A, Le Marouille-Girardon S, Millan MJ. Peglion JL, et al. Among authors: canton h. J Med Chem. 1995 Sep 29;38(20):4044-55. doi: 10.1021/jm00020a020. J Med Chem. 1995. PMID: 7562940

Cite

Share

10

Cite

Share

Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing.

Canton H, Emeson RB, Barker EL, Backstrom JR, Lu JT, Chang MS, Sanders-Bush E. Canton H, et al. Mol Pharmacol. 1996 Oct;50(4):799-807. Mol Pharmacol. 1996. PMID: 8863824

Cite

Share